← FDA DRUG APPROVALS

FDA ANDA · ANDA088676

METHYLPREDNISOLONE SODIUM SUCCINATE

Sponsor: ABRAXIS PHARM

APPLICATION
ANDA088676
TYPE
ANDA
ORIGINAL APPROVAL
1984-06-08
LATEST ACTION
1989-12-18
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

METHYLPREDNISOLONE SODIUM SUCCINATEDiscontinued
METHYLPREDNISOLONE SODIUM SUCCINATE EQ 40MG BASE/VIAL · INJECTABLE · INJECTION

Approval history

1989-12-18Labeling · Supplement 16AP
1989-02-27Labeling · Supplement 15AP
1984-06-08OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →